270 related articles for article (PubMed ID: 26359290)
1. Multiple sclerosis associated genetic variants of CD226 impair regulatory T cell function.
Piédavent-Salomon M; Willing A; Engler JB; Steinbach K; Bauer S; Eggert B; Ufer F; Kursawe N; Wehrmann S; Jäger J; Reinhardt S; Friese MA
Brain; 2015 Nov; 138(Pt 11):3263-74. PubMed ID: 26359290
[TBL] [Abstract][Full Text] [Related]
2. CD226 ligation protects against EAE by promoting IL-10 expression via regulation of CD4+ T cell differentiation.
Zhang R; Zeng H; Zhang Y; Chen K; Zhang C; Song C; Fang L; Xu Z; Yang K; Jin B; Wang Q; Chen L
Oncotarget; 2016 Apr; 7(15):19251-64. PubMed ID: 26942885
[TBL] [Abstract][Full Text] [Related]
3. Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226.
Fuhrman CA; Yeh WI; Seay HR; Saikumar Lakshmi P; Chopra G; Zhang L; Perry DJ; McClymont SA; Yadav M; Lopez MC; Baker HV; Zhang Y; Li Y; Whitley M; von Schack D; Atkinson MA; Bluestone JA; Brusko TM
J Immunol; 2015 Jul; 195(1):145-55. PubMed ID: 25994968
[TBL] [Abstract][Full Text] [Related]
4. The CD6 multiple sclerosis susceptibility allele is associated with alterations in CD4+ T cell proliferation.
Kofler DM; Severson CA; Mousissian N; De Jager PL; Hafler DA
J Immunol; 2011 Sep; 187(6):3286-91. PubMed ID: 21849685
[TBL] [Abstract][Full Text] [Related]
5. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
[TBL] [Abstract][Full Text] [Related]
6. HLA-E restricted CD8+ T cell subsets are phenotypically altered in multiple sclerosis patients.
Pannemans K; Broux B; Goris A; Dubois B; Broekmans T; Van Wijmeersch B; Geraghty D; Stinissen P; Hellings N
Mult Scler; 2014 Jun; 20(7):790-801. PubMed ID: 24144875
[TBL] [Abstract][Full Text] [Related]
7. CD226 deficiency on regulatory T cells aggravates renal fibrosis via up-regulation of Th2 cytokines through miR-340.
Mu Y; Zhang J; Liu Y; Ma J; Jiang D; Zhang X; Yi X; Cheng K; Shen S; Yang Y; Zhuang R; Zhang Y
J Leukoc Biol; 2020 Apr; 107(4):573-587. PubMed ID: 31802539
[TBL] [Abstract][Full Text] [Related]
8. New candidates for CD4 T cell pathogenicity in experimental neuroinflammation and multiple sclerosis.
Hoppmann N; Graetz C; Paterka M; Poisa-Beiro L; Larochelle C; Hasan M; Lill CM; Zipp F; Siffrin V
Brain; 2015 Apr; 138(Pt 4):902-17. PubMed ID: 25665584
[TBL] [Abstract][Full Text] [Related]
9. Astrocytic Fas ligand expression is required to induce T-cell apoptosis and recovery from experimental autoimmune encephalomyelitis.
Wang X; Haroon F; Karray S; Martina Deckert ; Schlüter D
Eur J Immunol; 2013 Jan; 43(1):115-24. PubMed ID: 23011975
[TBL] [Abstract][Full Text] [Related]
10. CD226 attenuates Treg suppressive capacity via CTLA-4 and TIGIT during EAE.
Wang N; Liang S; Jin J; Fang L; Ma Q; Wang X; Song Y; Chen L
Immunol Res; 2019 Dec; 67(6):486-496. PubMed ID: 31919790
[TBL] [Abstract][Full Text] [Related]
11. TNFR2 on non-haematopoietic cells is required for Foxp3+ Treg-cell function and disease suppression in EAE.
Tsakiri N; Papadopoulos D; Denis MC; Mitsikostas DD; Kollias G
Eur J Immunol; 2012 Feb; 42(2):403-12. PubMed ID: 22105853
[TBL] [Abstract][Full Text] [Related]
12. A 3'-untranslated region variant is associated with impaired expression of CD226 in T and natural killer T cells and is associated with susceptibility to systemic lupus erythematosus.
Löfgren SE; Delgado-Vega AM; Gallant CJ; Sánchez E; Frostegård J; Truedsson L; de Ramón Garrido E; Sabio JM; González-Escribano MF; Pons-Estel BA; D'Alfonso S; Witte T; Lauwerys BR; Endreffy E; Kovács L; Vasconcelos C; Martins da Silva B; Martín J; Alarcón-Riquelme ME; Kozyrev SV
Arthritis Rheum; 2010 Nov; 62(11):3404-14. PubMed ID: 20669283
[TBL] [Abstract][Full Text] [Related]
13. An acidic polysaccharide of Panax ginseng ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells.
Hwang I; Ahn G; Park E; Ha D; Song JY; Jee Y
Immunol Lett; 2011 Aug; 138(2):169-78. PubMed ID: 21524666
[TBL] [Abstract][Full Text] [Related]
14. CD44 variant isoforms control experimental autoimmune encephalomyelitis by affecting the lifespan of the pathogenic T cells.
Ghazi-Visser L; Laman JD; Nagel S; van Meurs M; van Riel D; Tzankov A; Frank S; Adams H; Wolk K; Terracciano L; Melief MJ; Sabat R; Günthert U
FASEB J; 2013 Sep; 27(9):3683-701. PubMed ID: 23752202
[TBL] [Abstract][Full Text] [Related]
15. Recovery of CD226-TIGIT
Long Y; Wang C; Xia C; Li X; Fan C; Zhao X; Liu C
Immunol Lett; 2020 Feb; 218():30-39. PubMed ID: 31883787
[TBL] [Abstract][Full Text] [Related]
16. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
Shen X; Niu C; König R
Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
[TBL] [Abstract][Full Text] [Related]
17. Increased CD226 Expression on CD8+ T Cells Is Associated with Upregulated Cytokine Production and Endothelial Cell Injury in Patients with Systemic Sclerosis.
Ayano M; Tsukamoto H; Kohno K; Ueda N; Tanaka A; Mitoma H; Akahoshi M; Arinobu Y; Niiro H; Horiuchi T; Akashi K
J Immunol; 2015 Aug; 195(3):892-900. PubMed ID: 26109642
[TBL] [Abstract][Full Text] [Related]
18. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms in the FOXP3 gene are associated with increased risk of relapsing-remitting multiple sclerosis.
Eftekharian MM; Sayad A; Omrani MD; Ghannad MS; Noroozi R; Mazdeh M; Mirfakhraie R; Movafagh A; Roshanaei G; Azimi T; Inoko H; Taheri M
Hum Antibodies; 2016; 24(3-4):85-90. PubMed ID: 27792007
[TBL] [Abstract][Full Text] [Related]
20. Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosis.
Janssens K; Van den Haute C; Baekelandt V; Lucas S; van Horssen J; Somers V; Van Wijmeersch B; Stinissen P; Hendriks JJ; Slaets H; Hellings N
Brain Behav Immun; 2015 Mar; 45():180-8. PubMed ID: 25514345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
